COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Next Generation Personalized Neuroblastoma Therapy (NEPENTHE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02780128
Recruitment Status : Recruiting
First Posted : May 23, 2016
Last Update Posted : January 28, 2020
Novartis Pharmaceuticals
Foundation Medicine
Information provided by (Responsible Party):
Yael P Mosse, Children's Hospital of Philadelphia

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : May 2026